The future of stem cells is extremely promising. With the advent of regenerative medicine has come a revolution in medical therapy, and at the forefront of this new direction are stem cells. From neuro-degenerative diseases such as Alzheimer’s disease and Parkinson’s disease, to dentistry and sports medicine, there are few areas where stem cells are not poised to play a game changing role. This is because the Mesenchymal stem cells (MSCs) found in dental pulp can differentiate into a variety of cell types including tissue, bone, cartilage, muscle, and nerves.
Although Mesencyhmal stem cells are not currently approved for use by the FDA, they are being evaluated in dozens of clinical studies throughout the world. These studies are investigating future treatments for cancer, diabetes, spinal cord injuries, heart disease, strokes, and many other conditions. Scientists are very optimistic that new cutting edge therapies will result from this research. Benefits of banking dental stem cells, while prevalent now, will be overwhelmingly prominent in the future with more treatments and trials coming every day.
Please note: National Dental Pulp Laboratory, Inc.’s activities for New York State residents are limited to collection of teeth and storage of tooth pulp from autogeneic donors. National Dental Pulp Laboratory, Inc.’s possession of a New York State license for such collection and storage does not indicate approval or endorsement of possible future uses or future suitability of dental pulp-derived stromal cells.